The post Uniswap deploys CCA token launch feature on Base appeared on BitcoinEthereumNews.com. Uniswap rolled out its Continuous Clearing Auctions feature on BaseThe post Uniswap deploys CCA token launch feature on Base appeared on BitcoinEthereumNews.com. Uniswap rolled out its Continuous Clearing Auctions feature on Base

Uniswap deploys CCA token launch feature on Base

Uniswap rolled out its Continuous Clearing Auctions feature on Base, giving developers a new way to launch tokens on-chain with built-in price discovery and liquidity setup.

Summary

  • Uniswap’s CCA feature is now live on Base for permissionless token launches.
  • The system discovers a market price before seeding liquidity on Uniswap v4.
  • The rollout follows early CCA use in late 2025 and expands access to Base builders.

Uniswap has introduced its CCA feature on Base, giving developers a new way to launch tokens on-chain with built-in price discovery and automatic liquidity.

Uniswap confirmed the rollout on Jan. 22, with the CCA framework now available to builders using Uniswap (UNI) v4 on the Base network.

What the CCA deployment on Base enables

With CCA live, teams can run fully on-chain token auctions that sell tokens gradually rather than all at once. The process clears bids block by block, allowing prices to form naturally before trading begins.

After an auction finishes, liquidity is added automatically to a Uniswap v4 pool at the final cleared price. This removes the need for manual pool creation and helps avoid common launch problems tied to sharp price swings at listing.

The feature is open to all Base developers and does not require approvals or special access. Any team building on the network can use CCA as part of their launch process.

The auction model is meant to create a fairer starting point for new tokens. Instead of fixed-price sales or single-moment launches, distribution happens over time, reducing the impact of sniping, front-running, and bundled transactions.

Teams can also adjust auction settings to fit their needs while keeping the entire process on-chain and transparent.

CCA was rolled out in late 2025 and has already been used by projects such as Aztec Network for early price discovery and liquidity setup.

Why the Base rollout matters

Uniswap is making structured token launches accessible on one of the busiest Ethereum (ETH) layer-2 networks by expanding the feature to Base. Developers can now handle auctions, pricing, and liquidity through a single workflow on Uniswap v4.

The update adds to Base’s growing decentralized finance toolkit, especially for teams moving away from private sales or unstable fair-launch models.

Uniswap has been expanding its v4 tools across several chains in recent months. Along with integrating with partners like Revolut for fiat access and Ledger for safe swaps via its trading API, the protocol has also gone live on networks like Monad and X Layer.

Source: https://crypto.news/uniswap-launches-cca-token-auctions-base-2026/

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.00079
$0.00079$0.00079
+6.77%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26